Search Results - "Mercogliano, Florencia"
-
1
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Published in Frontiers in oncology (22-04-2020)“…Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality by malignancy in women and represents a main problem for public…”
Get full text
Journal Article -
2
JUVENILE EXPOSURE TO A HIGH FAT DIET PROMOTES BEHAVIORAL AND LIMBIC ALTERATIONS IN THE ABSENCE OF OBESITY
Published in Psychoneuroendocrinology (01-10-2016)“…Highlights • Mice fed with high fat diet (HFD) developed hyperinsulinemia, dyslipidemia and prothrombotic risk. • The liver of HDF mice showed high…”
Get full text
Journal Article -
3
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Published in Frontiers in oncology (22-05-2023)“…Immunotherapy has changed the course of cancer treatment. The initial steps were made through tumor-specific antibodies that guided the setup of an antitumor…”
Get full text
Journal Article -
4
Emerging Targeted Therapies for HER2-Positive Breast Cancer
Published in Cancers (26-03-2023)“…Breast cancer is the most common cancer in women and the leading cause of death. HER2 overexpression is found in approximately 20% of breast cancers and is…”
Get full text
Journal Article -
5
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth
Published in Endocrine-related cancer (01-04-2013)“…Stat3 is a signaling node for multiple oncogenic pathways and is therefore frequently active in breast cancer. As experimental and clinical evidence reveals…”
Get full text
Journal Article -
6
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
Published in Cancers (02-02-2021)“…Tumor necrosis factor alpha (TNFα) is a pleiotropic cytokine known to have contradictory roles in oncoimmunology. Indeed, TNFα has a central role in the onset…”
Get full text
Journal Article -
7
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
Published in Frontiers in oncology (06-12-2019)“…Endometrial cancer (EC) is the second most common gynecological cancer worldwide. Myometrial invasion (MI) is a key event in EC dissemination. This study aimed…”
Get full text
Journal Article -
8
Inhibition of MHC‐I by Brucella abortus is an early event during infection and involves EGFR pathway
Published in Immunology and cell biology (01-04-2017)“…Brucella abortus is able to persist inside the host despite the development of potent CD8+ T‐cell responses. We have recently reported the ability of B…”
Get full text
Journal Article -
9
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
Published in Breast cancer research : BCR (02-11-2023)Get full text
Journal Article -
10
Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways
Published in Frontiers in oncology (23-01-2024)“…[This corrects the article DOI: 10.3389/fonc.2019.01306.]…”
Get full text
Journal Article -
11
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
Published in Breast cancer research : BCR (17-12-2013)“…The role of the progesterone receptor (PR) in breast cancer remains a major clinical challenge. Although PR induces mammary tumor growth, its presence in…”
Get full text
Journal Article -
12
RETRACTED ARTICLE: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
Published in Breast cancer research : BCR (17-12-2013)“…Abstract Introduction The role of the progesterone receptor (PR) in breast cancer remains a major clinical challenge. Although PR induces mammary tumor growth,…”
Get full text
Journal Article -
13
Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth
Published in Molecular endocrinology (Baltimore, Md.) (01-10-2015)“…Accumulated findings have demonstrated the presence of bidirectional interactions between progesterone receptor (PR) and the ErbB family of receptor tyrosine…”
Get full text
Journal Article -
14
Abstract PO2-18-05: Blocking soluble TNF to Improve potency of trastuzumab deruxtecan by increasing internalization and antitumor innate immune response in a resistant HER2-positive breast cancer model
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Abstract Background Trastuzumab deruxtecan (T-DXd) administration improves response for patients with HER2-positive metastatic breast cancer (HER2+ BC)…”
Get full text
Journal Article -
15
Pituitary stem cells: past, present and future perspectives
Published in Nature reviews. Endocrinology (01-02-2024)“…Pituitary cells that express the transcription factor SOX2 are stem cells because they can self-renew and differentiate into multiple pituitary…”
Get full text
Journal Article -
16
Abstract P1-11-12: Soluble TNFα blockade enhances trastuzumab deruxtecan antitumor effect in HER2-positive breast cancer model
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background. Clinical trials have demonstrated that trastuzumab deruxtecan (T-DXd) provides a durable responses for patients with HER2-positive and…”
Get full text
Journal Article -
17
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
Published in Breast cancer research : BCR (06-12-2014)“…The transcription factor GATA3 is involved in mammary gland development and is crucial for the maintenance of the differentiated status of luminal epithelial…”
Get full text
Journal Article -
18
ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
Published in Journal of the Endocrine Society (01-11-2022)“…Abstract Enhancer of Zeste homolog 2 (EZH2) is a histone methyltransferase which catalyzes the trimethylation of lysine 27 of histone H3 (H3K27me3), an…”
Get full text
Journal Article -
19
Comprehensive Identification of Pathogenic Gene Variants in Patients With Neuroendocrine Disorders
Published in The journal of clinical endocrinology and metabolism (01-07-2021)“…Abstract Purpose Congenital hypopituitarism (CH) can present in isolation or with other birth defects. Mutations in multiple genes can cause CH, and the use of…”
Get full text
Journal Article -
20
OR17-02 Combining Transcriptomics And Proteomics To Unveil Possible PROP1 Interactors During Embryonic Pituitary Development
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: L. Iglesias Garcia: None. M.F. Mercogliano: None. C. Schuster: None. L. Cheung: None. S.A. Camper: None. M. Marti: None. M.I…”
Get full text
Journal Article